Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2015 Dec 20.

Published in final edited form as: J Urol. 2014 Aug 9;192(6):1642–1648. doi: 10.1016/j.juro.2014.08.002

Table 1.

Patient demographics, MP-MRI assigned prostate cancer suspicion scores and fusion guided biopsy findings by PSA cutoff

	PSA Cutoff (ng/ml)
	0–Less Than 2.5	2.5–Less Than 4	4–10	Greater Than 10	Overall
No. pts (%)	81 (8.1)	131 (13.1)	513 (51.1)	278 (27.7)	1,003
Mean ± SD age	59.4 ± 7.4	60.6 ± 8.0	62.0 ± 7.4	63.6 ± 7.1	62.1 ± 7.5
Mean ± SD MRI:
Prostate vol (ml)	36 ± 15	45 ± 17	57 ± 30	74 ± 43	59 ± 34
No. lesions/pt	2.4 ± 1.1	2.8 ± 1.3	2.6 ± 1.3	2.8 ± 1.3	2.7 ± 1.3
No. anterior lesions/pt	0.7 ± 1.2	1.1 ± 1.5	1.3 ± 1.9	1.8 ± 2.2	1.4 ± 1.9
Mean ± SD No. biopsy cores/pt	17.0 ± 2.4	17.8 ± 2.9	17.5 ± 2.8	17.7 ± 2.7	17.6 ± 2.7
No. prior neg biopsy (%)	8 (9.9)	13 (9.9)	100 (19.5)	74 (26.6)	195 (19.4)
No. prostate Ca (%)^*	36 (44.4)	75 (57.3)	284 (55.4)	169 (60.8)	564

^*

On targeted or 12-core biopsy.